7
Clinical Trials associated with HRS-1780Open-Label Assessment of the Effects of Itraconazole and Rifampicin on HRS-1780 Pharmacokinetics in Healthy Subjects
The study was designed to evaluate the pharmacokinetic effects of itraconazole and rifampicin on HRS-1780 after oral administration of HRS-1780 tablets in healthy subjects
伊曲康唑及利福平对HRS-1780在健康受试者中开放、固定序列的药代动力学影响研究
[Translation] Effects of itraconazole and rifampicin on the pharmacokinetics of HRS-1780 in open and fixed sequence in healthy subjects
主要研究目的:
评价伊曲康唑/利福平对健康受试者口服HRS-1780片后HRS-1780的药代动力学(PK)影响。
评价健康受试者单剂量口服HRS-1780片及与伊曲康唑/利福平联合用药的安全性
[Translation] Main study objectives:
To evaluate the effect of itraconazole/rifampicin on the pharmacokinetics (PK) of HRS-1780 after oral administration of HRS-1780 tablets to healthy subjects.
To evaluate the safety of single-dose oral administration of HRS-1780 tablets and combination with itraconazole/rifampicin in healthy subjects
A Phase II Clinical Study of Efficacy and Safety of HRS-1780 Tablets and Henagliflozin Proline Tablets in the Treatment of Patients With Chronic Kidney Disease (Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Design)
The objective of this study was to evaluate the efficacy of HRS-1780 tablets or Henagliflozin Proline tablets in patients with chronic kidney disease by evaluating UACR change from baseline to Week 13
100 Clinical Results associated with HRS-1780
100 Translational Medicine associated with HRS-1780
100 Patents (Medical) associated with HRS-1780
100 Deals associated with HRS-1780